Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Oxford Molecular Group/Alizyme

Executive Summary

Oxford Molecular Group/Alizyme: British companies agree to collaborate on research identifying agents for the treatment of obesity and related disorders, Oxford Molecular and Alizyme announce June 10. Collaboration will link Oxford Molecular's rational drug design, synthetic chemistry and biological screening abilities with Alizyme's discovery program to identify inhibitors of pancreatic lipase, which digests fatty foods...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028358

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel